A61K 31/5383
Ortho- or peri-condensed with heterocyclic ring systems
Official title: ortho- or peri-condensed with heterocyclic ring systems
A61K31/5383 (Ortho- or peri-condensed with heterocyclic ring systems) appears on 764 US grants and 1,410 published applications in this corpus.
Search patents in A61K- Granted patents
- 764
- Published applications
- 1,410
- Assignees
- 569
- Inventors
- 3,852
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 5 | 4 |
| 2002 | 6 | 8 |
| 2003 | 6 | 20 |
| 2004 | 7 | 7 |
| 2005 | 2 | 9 |
| 2006 | 6 | 19 |
| 2007 | 3 | 25 |
| 2008 | 8 | 15 |
| 2009 | 15 | 19 |
| 2010 | 11 | 35 |
| 2011 | 11 | 25 |
| 2012 | 20 | 34 |
| 2013 | 38 | 53 |
| 2014 | 44 | 86 |
| 2015 | 48 | 91 |
| 2016 | 47 | 74 |
| 2017 | 80 | 91 |
| 2018 | 53 | 79 |
| 2019 | 54 | 67 |
| 2020 | 55 | 78 |
| 2021 | 53 | 85 |
| 2022 | 35 | 64 |
| 2023 | 43 | 72 |
| 2024 | 36 | 109 |
| 2025 | 37 | 137 |
| 2026 | 33 | 104 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Sirt6 activators6 Oct 2026US 12,753,180 B2Board of Regents, The University of Texas System
- Combinatory treatment29 Sep 2026US 12,746,216 B2Arivin Therapeutics Oy
- Quinoxaline derivatives and uses thereof22 Sep 2026US 12,741,976 B2Black Diamond Therapeutics, Inc.
- Macrocyclic derivative and use thereof15 Sep 2026US 12,734,177 B2Guangzhou Joyo Pharmatech Co., Ltd
- PARP inhibitor containing piperazine structure. preparation method therefor and pharmaceutical use thereof15 Sep 2026US 12,735,432 B2Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Drug-containing particle8 Oct 2026US 2026/0306409 A1Towa Pharmaceutical Co., Ltd.
- Tricyclic compounds for treatment of bacterial infections8 Oct 2026US 2026/0308172 A1Hoffmann-La Roche Inc.
- Hexahydro[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine deuterated derivative, pharmaceutical composition thereof, preparation method therefor, and anti-influenza use thereof8 Oct 2026US 2026/0308174 A1Changsha Jingyi Pharmaceutical Technology Co., Ltd
- Kif18a inhibitor compound, and pharmaceutical composition and preparation method therefor and use thereof1 Oct 2026US 2026/0294927 A1Changchun Genescience Pharmaceutical Co., Ltd.
- Heterocyclic compounds as parp1 inhibitors1 Oct 2026US 2026/0297102 A1Synnovation Therapeutics, Inc.
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Intermediates useful for making 2,4-pyrimidinediamine compounds192US 7,060,827 B2Rigel Pharmaceuticals, Inc. · 2006
- Quinoline derivatives as PI3 kinase inhibitors178US 8,138,347 B2GlaxoSmithKline LLC · 2012